The average number of quotes went from just over four to ten per risk, showing the continued excess supply of underwriting capacity either due to reduced deal flow, increases in human capital, or new entrants to the market.
As we saw above, the lowest price came in at 2.98%, which is a significant drop. What’s just as noteworthy is that the highest pricing has also dropped from 5.9% in March to 4% in April, again a substantial saving for deals priced this month as opposed to the previous month.
Trends in RWI "Heightened Risk" You Should Know
Anyone experienced in the process of placing an RWI policy should be familiar with the areas of heightened risk listed on every NBIL. These are the deal-specific areas on which underwriters will focus during their review of the diligence conducted by the buyer’s team of advisors. Should diligence be lacking in one of these areas, underwriters will likely seek to incorporate an exclusion in the policy for that portion of the risk.
Ukraine and Russia continue to be an area of heightened risk. However, we have seen underwriters drop the blanket approach and focus on those deals where it’s likely to be an actual issue rather than wanting to dig deep on every deal.
Three Cases of RWI Litigation
Arbitration as the first port of call is standard in RWI policies. Litigation around RWI has historically been difficult to find. There are currently three active cases in the court system right now. They have been around for a while, but we think it’s worth exploring them a little.
The three cases are:
Novolex Holdings, LLC v. Illinois Union Ins. Co, Index No. 656825
This dispute centers around the seller’s knowledge of the intention of its third-largest customer to significantly reduce business. This is currently pending a decision on the Insured’s summary judgment motion.
You can find a more thorough analysis here: Novolex Case Brings Lessons On R&W Insurance – Lexology
WPP Group USA, Inc. v. RB/TDM Investors, LLC, Index No. 656825
This case centers on whether financial projections were misrepresented and is currently in discovery. It’s interesting to note that in the WPP case the insured had the right to decide between arbitration and litigation and chose litigation.
You can find a more thorough analysis here: WPP Grp. U.S. v. RB/TDM Inv’rs , 2021 N.Y. Slip Op. 30160 | Casetext Search + Citator
pH Beauty Holdings III, inc. v. Certain underwriters at Lloyd’s, case no 21-1586 BLS
This case centers on the failure to account for millions of dollars in promotion expenses, which resulted in an inflation of the purchase price.
You may find more details of the case here: PH Beauty sues insurers to cover losses of ‘inflated’ deal | Reuters
None of these cases are resolved at this point, and extensive discovery is expected. We, therefore, anticipate that unless a settlement can be achieved quickly or through arbitration, long-term disputes are likely to be the norm.
All relate to claims of more than $10 million. We would expect to see litigation come into play for higher limit claims and don’t see this trend moving down to smaller claims. All three cases relate either to the accuracy of financial statements or material customers. We hear from the market that claims around material customers are much more prevalent and rising recently. While this is not relevant to the above, we expect this cause of conflict to continue. Material contract claims are where we see Covid issues materialize in the sense that Covid is often the inciting incident leading to a failure of a supplier or the customer to be able to maintain existing conditions.
What does this mean for you? While these go through the courts, it will be interesting to see how this impacts the buyer’s desire to maintain the right to litigate in court, whether expressly or by remaining silent on venue options. We imagine insurers will resist, because by and large they want to arbitrate as the first port of call. In some cases, arbitration is the only method of dispute resolution.
Going Forward: RWI Trends to Keep an Eye On
The market has returned to early 2021 levels in terms of pricing and competition. We imagine this will continue into the foreseeable future as the war in Ukraine and domestic economics play out, affecting the M&A market and the number of submissions.
The market has come to terms with the Ukrainian situation far more nimbly than it did COVID-19 and we also expect this to continue.
We anticipate more negotiation and pressure on dispute resolution clauses and more diligence on material contract reps going forward.
